Micro Flashcards
III.11 Adenovirus characteristics
- dsDNA
- Icosahedral capsid
- Naked
- Fiber antigens for attachment to receptor and agglutination of RBCs
- Human adenovirus has 57 serotypes (number 14 most severe), differentiated by hemagglutinin inhibition
III.11 Adenovirus Transmission
Contact, respiratory droplets, feces and aerosol
III.11 Adenovirus Pathogenesis
Pentons of the icosahedral capsid contains fibers that acts as hemagglutinin (toxic to cells)
- In permissive cells: virus is lytic – production occurs/replication
- In non-permissive cells: can be chronic of oncogenic (transformation occurs)
III.11 Adenovirus Clinical
a) Respiratory diseases: Tonsillitis (#1 cause), pharyngitis, pharyngoconjunctival fever, pneumonia, pertussis-like symptoms
b) Enteric infection: Watery diarrhea
c) Eye infection: Epidemic keratoconjunctivitis, follicular conjunctivitis
d) UTI: Acute hemorrhagic cystitis
e) Immune suppressed patients: Pneumonia, hepatitis, encephalitis
* Reactivation can occur in case of immunosuppressed patients
III.11 Adenovirus Ddx
Serology, cultivation on HeLA, epithelial cell culture –> strong CPE (cytopathic effect), rapid test for diarrhea
III.11 Adenovirus treatment
none - supportive
III.11 Adenovirus vaccine
Live attenuated (serotype 4 and 7) –> only for military recruits
III.12 Herepesvirus : HSV1 and HSV2 characteristics
- dsDNA – linear
- Icosahedral capsid – Encode glycoproteins for attachment, fusion, immune escape
- Enveloped – Sensitive to acid, detergents etc.
- α-herpesvirus
III.12 Herepesvirus : HSV1 and HSV2 Transmission
Saliva, vaginal secretions, transcervical (perinatal), TORCH
III.12 Herepesvirus : HSV1 and HSV2 Pathogenesis
The virus targets Mucoepithelial cells:
Viral replication in site of infection –> local nerve ending invasion –> retrograde axonal transport to dorsal root ganglia –> latency
*Generally: acute infection (early proteins) –> latency (viral genome present, but no viral proteins produced – periodic reactivation i.e. due to UV, stress etc.
III.12 Herepesvirus : HSV1 clinical
- Herpes labialis (cold sores) and gingivostomatitis Keratoconjuntivitis
- Herpetic Whitlow – rash on fingers
- Erythema multiforme – back of hands/feet
- Encephalitis – due to necrosis and hemorrhage of neurons
III.12 Herepesvirus : HSV2 clinical
- Genital herpes – inguinal lymphadenopathy and painful genital lesion
- Neonatal herpes – transcervical or transplacental (liver involvement/encephalitis)
- Aseptic meningitis
III.12 Herepesvirus : HSV1 and HSV2 ddx
Scrapings of the base of lesions – cultivation on HeLA
PCR of CSF – for encephalitis
Serology to distinguish HSV-1 and HSV-2
Genital infections – virus isolation from vesicles –> Tzanck smear
*Tzanck smear - Cytology that will show multinucleated giant cells, intranuclear eosinophilic Cowdry type A inclusion bodies are also seen
III.12 Herepesvirus : HSV1 and HSV2 treatment
Acyclovir (inhibition of DNA synthesis) – does not prevent latent infection
III.13 Herpesvirus - VZV - Varicella Zoster Virus characteristics
- dsDNA
- Icosahedral capsid ~ 150nm
- Enveloped
- α-herpesvirus
III.13 Herpesvirus - VZV - Varicella Zoster Virus transmission
Respiratory droplets, contact(rare), TORCH
III.13 Herpesvirus - VZV - Varicella Zoster Virus Pathogenesis
Primary infection in mucosa of respiratory tract –>blood and lymphatics –> dissemination to skin –> dermal vesiculopapular rash –> chicken pox –> latency in sensory ganglia –> reactivation –> migrates along neural pathways to skin –> Shingles
III.13 Herpesvirus - VZV - Varicella Zoster Virus Clinical
Primary infection: Varicella (chicken pox)
- Asynchronous rash forms small, itchy blisters all over the body (different stages; Macula, vesicles, scabs).
- Presents with fever, headache, pharyngitis, malaise (general discomfort), rhinitis.
- Adults present with pneumonia, encephalitis. Highly contagious!
Secondary infection (recurrence): Zoster (Shingles)
- Pain in a given dermatome with rash limited to said dermatome.
- Develops in immunocompromised patients
- Can cause post-herpetic neuralgia (chronic pain that lasts for years due to damage of nerves addected by virus) *
Herpes Zoster ophthalmicus – Vision loss when CNV/I is affected
Congenital varicella syndrome –> Limb hypoplasia, cutaneous dermal scarring, blindness
III.13 Herpesvirus - VZV - Varicella Zoster Virus ddx
Serology –> Examine skin lesion scraping
Tzanck smear –> Will show multinucleated giant cells, Cowdry bodies
III.13 Herpesvirus - VZV - Varicella Zoster Virus treatment
Acyclovir
III.13 Herpesvirus - VZV - Varicella Zoster Virus Vaccine
Passive (VZ-Ig) – immunosuppressed patient, ineffective in active cases
Active; live, attenuated – cell mediated immunity
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) characteristics
- large linear dsDNA
- Icosahedral capsid
- Enveloped
- gamma-herpesvirus
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) transmission
Saliva and respiratory secretions (90% of population is seropositive)
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) pathogenesis
Infects permissive nasopharyngeal epithelial cells, salivary and lymphoid tissues.
Latent infection in B-cells;
Binds CDRI and produce LMP1 (latent membrane protein 1) –>
a) NFKB activation and B-cell proliferation
b) Bcl2 ⊣ apoptosis
This causes production of atypical CD8+ T-cells – Downey cells against it
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) clinical
a) Infectious mononucleosis – “Kissing disease” (transmitted by saliva)
Exudative tonsillitis, lymphadenopathy, splenomegaly.
Presence of atypical lymphocytes used to distinguish from CLL.
Paul-Bunnel reaction positive – it has heterophile antibody
b) Hairy oral leukoplakia – non-precancerous hyperproliferation of lingual epithelial cells
oral thrush
c) Burkitt lymphoma – Tumor growth in lymph nodes; maxilla and mandible (joint).
Due to translocation of c-myc oncogene which becomes active promotor (t(8;14)).
Endemic type – Associated with endemic areas of malaria
Sporadic/non-African type – commonly affects the ileocecal region
Immunodeficient type – associated with AIDS
d) Nasopharyngeal carcinoma – commonly in Asians. Tumor cell of epithelial origin
e) Hodgkin’s (B-cell) lymphoma – Dx by presence of Reed-Sternberg cells
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) ddx
Blood smear –> Downey cells
Monospot test – a form of heterophile Ab-test –> heterophile Abs positive – IgM agglutination to Paul-Bunnel antigens on sheep RBCs.
Heterophile Abs are produced due to B-cell induction by EBV
III.14 - Herpesvirus - Epstein-Barr Virus (HHV-4) treatment
symptomatic treatment for mono
III.15 - Herpes - Cytomegalovirus (HHV-5) characteristics
- dsDNA
- Icosahedral capsid ~ 150nm
- Enveloped
- beta-herpesvirus
- Latency in monocytes, macrophages, T-cells
III.15 - Herpes - Cytomegalovirus (HHV-5) Transmission
Direct and sexual contact by bodily fluids
transplantation
TORCH
III.15 - Herpes - Cytomegalovirus (HHV-5) Pathogenesis
Infects salivary glands epithelial cells by binding to the integrin receptors.
Established persistent in fibroblasts, epithelial cells, macrophages, etc.
Latency is established in mononuclear leukocytes (B-cells, T-cells, macrophages).
Reactivation occurs by immunosuppression.
III.15 - Herpes - Cytomegalovirus (HHV-5) clinical
a) Congenital CMV infection – CNS damage causes sensorineural deafness.
Periventricular calcifications lead to seizures. Thrombocytic purpura w/ “blueberry Muffin” rash, jaundice, hepatosplenomegaly, pneumonitis, fetal hydrops
b) Mononucleosis – negative heterophile
c) Esophagitis – with linear ulcerations
d) CMV colitis – with ulcerated walls
e) Interstitial pneumonitis – leads to severe systemic infection due to reactivation in transplant patients or AIDS
f) CMV Retinitis – common in AIDS patients with a CD4+ count under 50 cells/&L. Blind spots, vision loss, retinal
necrosis and pizza pie retinopathy on fundoscopic exam
g) Hepatitis – in pregnancy
III.15 - Herpes - Cytomegalovirus (HHV-5) ddx
Histology –> intranuclear basophilic Owl’s eyes inclusions. Take sample from buffy coat (the layer of WBC from a centrifuged blood) and stain with Pap or H&E
PCR –> DNA detection and amplification
Cell culture –> fibroblast culture
Serology –> ELISA, Paul-Bunnel antigen detection
III.15 - Herpes - Cytomegalovirus (HHV-5) treatment
Immunocompetent people which are asymptomatic do not require treatment
Severe infection in immunocopromised people, Gancyclovir, Cidofovir and Foscarnet (for resistance, UL97 mut) can be given.
III.16 Herpesvirus - HHV6 characteristics
dsDNA
Icosahedral capsid ~ 150 nm
Enveloped
beta-herpesvirus
III.16 Herpesvirus - HHV6 Transmission
salvia
III.16 Herpesvirus - HHV6 Pathogenesis
Replicate in salivary glands, shed and transmitted through saliva.
Can also infect lymphocytes (mainly CD4+ T-cells) in peripheral blood
Can lead to immunosuppression by decreasing the CD4+ T-cells
III.16 Herpesvirus - HHV6 clinical
in immunocompromised (HHV6a)
- Encephalitis
- Pneumonitis
- Chorioretinitis
Neonatal HHV-6B ~ Roseda infantum (exanthema subitum)
- Primarily in children 3-6 months old
- Fever that could lead to febrile seizures
- Maculopapular rash that spares the face
III.16 Herpesvirus - HHV6 ddx
Clinical picture
PRC, serology – Virus isolation from lymphocytes
III.16 Herpesvirus - HHV6 treatment
Self-limited
Gancyclovir, symptomatic, no vaccine
III.16 Herpesvirus - HHV 7 clinical
Also causes Exanthema subitum, but less frequently than HHV-6. Same symptoms
Others: - Pytiriasis rosea (Herald patches), “gloves and socks syndrome” Severe cases: - encephalitis - flaccid paralysis - hepatitis, gastritis - lowered lymphocyte count - LAD - diarrhea
III.16 Herpesvirus - HHV8 characteristics
dsDNA
Icosahedral capsid
Enveloped
gamma-herpesvirus
III.16 Herpesvirus - HHV8 transmission
Saliva, sexual contact – higher prevalence in Russian men, Sub-Saharan Africa and Mediterranean
III.16 Herpesvirus - HHV8 pathogenesis
Infects mainly B-cells (like EBV), but also epithelial cells, monocytes etc.
HHV-8 activates VEGF
III.16 Herpesvirus - HHV8 clinical
a) Kaposi sarcoma
Opportunistic infection associated with AIDS
Lesions on nose, extremities, mucus membrane
Lesions may be plaque, patches, macule or nodule – arise from mesenchymal cells Angiogenesis within lesion causes violet color
Commonly affects hard palate, and also seen in GI
b) Primary effusion (B-cell) lymphoma
Large B-cell lymphoma located in body cavities
Characterized by pleural, peritoneal, pericardial fluid lymphomatous effusions
III.16 Herpesvirus - HHV8 ddx
Clinical, antibody detection, viral DNA by PCR
Differential diagnosis from bacillary angiomatosis (B. henslae) by microscopic exam (will show neutrophil infiltrate, instead of lymphocytes as with HHV-8)
III.16 Herpesvirus - HHV8 treatment
Liquid nitrogen
interferon-alpha
III. 17 Parvovirus characteristics
ssDNA
Icosahedral capsid ~20-25 nm (smallest virus)
No envelope
Erythrovirus –> Parvovirus B19 ~ only one to cause human disease
III. 17 Parvovirus transmission
Respiratory droplets, fomites, TORCH
III. 17 Parvovirus clinical
a) Erythema Infectiosum ~ “fifth disease”
Slapped cheek syndrome – starts as fever, then rash
Teenagers may develop papular purpuric gloves and socks syndrome Adults may develop arthralgia, arthritis and edema
b) Fetal hydrops
Can cross-placenta; occurs in the first 2 trimesters of pregnancy
This is due to CHF (congestive heart failure) leading to severe anemia and edema
c) Aplastic anemia
Infection can lead to lower erythropoiesis
This may cause anemia which is only significant in patients with blood disorders (i.e. sickle cell, Thalassemia, Hereditary spherocytosis)
Bone marrow depletion – severe situation if chronic anemia is present
III. 17 Parvovirus ddx
Clinical, serology
III. 17 Parvovirus treatment
self-limiting
III. 17 Parvovirus pathogenesis
Parvovirus B19
Target cells: Normoblasts –> failure of RBC production
III. 18 Papilloma Virus characteristics
cdsDNA
Icosahedral capsid
naked
III. 18 Papilloma Virus Transmission
Direct and sexual contact (can also infect children during delivery)
Infects the basal cell layer of the skin (stem cells) and mature as the cell matures up to the surface
The virus persists in basal layer and stays hidden from immune system
III. 18 Papilloma Virus ddx
Clinical – for cutaneous warts
PCR – to distinguish serotype
III. 18 Papilloma Virus treatment
Cryotherapy
Cidofovir
III. 18 Papilloma Virus prevention
Guardisol – using capsid proteins (recombinant)
III. 18 Polymoavirus characteristics
cdsDNA
Icosahedral capsid
naked
III. 18 Polymoavirus Transmission
Respiratory droplets, saliva
III. 18 Polymoavirus Pathogenesis
Infects tonsils and lymphocytes, then spreads by viremia to kidney.
secondary viremia occurs and become latent in immunocompetent or reactive in immunosuppressed.
1) BK virus (from first patient) ~ latency in kidney
Nephropathy (nephritis and urethral stenosis) and hemorrhagic cystitis (hematuria) in bone marrow transplanted patients (DDX; Adenovirus)
2) JC (John Cumingham) virus ~ latency in kidney, B-cells, monocytes ++
Progressive multifocal leukoencephalopathy (PML) ~ infection of oligodendrocytes causing demyelination of CNS.
Multifocal brain lesions in white matter (DDX; Toxoplasma)
Symptoms are deranged speech, vision and coordination loss, paralysis of limbs, death
Usually occurs in AIDS patients
III. 18 Polymoavirus ddx
MRI/CT
ELISA
PCR of CSF
III. 18 Polymoavirus treatment
none
III. 18 Papilloma Virus clinical
1) Mucosotropic genotypes
a) Low risk serotypes; 6-11 Condyloma Accuminata (anogenital warts) Laryngeal papilloma
b) High risk serotypes; 16-18, 31, 33
Pre-neoplastic condition (associated with dysplasia) CIN/VIN/VAIN, penis, anus, mouth, throat
E6 ⊣ p53
E7 ⊣ Retinoblastoma
2) Cutaneous genotypes; 1-4
Low risk serotypes
Hyperkeratosis (growth of basal and spinosum) leads to formation of warts
Common warts (2-4): Found on hands/fingers
Plantar warts (1): Found on soles – deeper and more painful
III.19 Poxvirus characteristics
dsDNA ~ replicates in cytoplasm
Complex structure ~ 300 nm (Biggest virus!)
Enveloped
2 lateral bodies
Variola virus ~ Smallpox
Vaccinia virus ~ Vaccination of smallpox
Cow pox virus ~ Share antigenic determinant with variola virus (Jenner)
III.19 Poxvirus transmission
Respiratory droplets, contact
III.19 Poxvirus clinical
1) Smallpox (Variola – minor or major depending on immune status)
Virus enters the upper respiratory tract and disseminates via lymphatics causing viremia After second viremia, it infects all dermal tissues and internal organs – “pocks”
5-7 day of incubation;
Flu-like symptoms for 2-4 days followed by a rash (macule – papule – vesicle – pustule –>
synchronous). The vesicles are deep and hemorrhagic.
2) Molluscum contagiosum virus Benign epithelial tumor (wart-like). Acquired by direct contact Common on trunk and genitalia. Treated by liquid nitrogen
III.19 Poxvirus ddx
Isolation from vesicles – intra-cytoplasmic eosinophilic
Guarnieri inclusion bodies (site of viral replication)
Embryonated egg – chorioallantoic membrane inoculation
Serology
III.19 Poxvirus vaccine
Live attenuated- Cowpox vaccine is efficient against cowpox and smallpox
III.20 Arenavirus characteristics
ssRNA ~ Ambisense, has both positive and negative sense sections
Helical ~ 50-300 nm
Enveloped with projections
Natural host; rodents
“Sandy” – ribosome granules of host cell origin
III.20 Arenavirus transmission
Zoonotic, rodents shedding virus via saliva, urine and feces
III.20 Arenavirus pathogenesis
Arenaviruses usually cause persistent infections. They infiltrate macrophages leading to release of IFN and cytokines that causes cell and vascular damage. T-cell induced effects will cause further tissue destruction. Incubation time is 10-14 days.
III.20 Arenavirus ddx
Grainy appearance on EM, serology, RT-PCR
III.20 Arenavirus treatment
Ribavirin for Lassa fever, supportive therapy for LCM
- Virus could be inactivated by heating, low pH, irradiation and detergents
III.20 Arenavirus -Lymphocytic choriomeningitis virus (LCM)
Ranges from asymptomatic (in immune competent) to aseptic meningitis
Biphasic disease; 10 phase with fever, flu-like symptoms and myalgia to the 20 phase with meningitis, encephalitis, lymphocytic infiltration of choroid plexus
III.20 Arenavirus - Lassavirus
Hemorrhagic fever with 50% mortality due to hypovolemic shock. May present with coagulopathy, petechia, no vasculitis
III.20 Arenavirus - Machupovirus
Similar symptoms to Lassavirus, but less severe * Different endemic areas
Lassa- Hemorrhagic fever with 50% mortality due to hypovolemic shock. May present with coagulopathy, petechia, no vasculitis
III.21 Bunyaviruses (Hanta-.. Crimean-Congo hemorrhagic fever virus) characteristics
ssRNA ~ 3 segments. Circular, negative
Helical capsid
Enveloped with projections
III.21 Bunyaviruses (Hanta-.. Crimean-Congo hemorrhagic fever virus) transmission
Arboviruses (arthropod-borne), except Hantavirus (rodent-borne)
III.21 Bunyaviruses- HantaVirus clinical
Hantavirus (aka Sin Nombre)
Transmission via rodent feces or urine
- Hemorrhagic fever with Renal syndrome (HFRS)
Hemorrhagic fever (leakage of RBC and plasma through endothelium)
Pre-renal azotemia - Pulmonary syndrome
Pulmonary edema due to capillary leak
III.21 Bunyaviruses (Hanta-.. Crimean-Congo hemorrhagic fever virus) ddx
PCR – Hantavirus
RVFP + CEO – ELISA
Crimean-Congo – ELISA
III.21 Bunyaviruses (Hanta-.. Crimean-Congo hemorrhagic fever virus) treatment
none
III.21 Bunyaviruses (Hanta-.. Crimean-Congo hemorrhagic fever virus) prevention
Inactivated Henta in Asia
III.21 Bunyaviruses Crimean-Congo hemorrhagic fever virus clinical
Crimean-Congo virus
Transmission via tick: Arbovirus/arthropod-borne - Crimean-Congo hemorrhagic fever (CCHF)
10 lesion involves leakage of RBCs and plasma through endothelium
Presents with fever, myalgia, headache, vomiting, diarrhea and bleeding into skin
Complications; liver failure, kidney damage, DIC, shock and death
III.22 Coronavirus characteristics
ssRNA, positive sense
Helical capsid
Enveloped ~ glycoproteins give a halo.
Three proteins (open reading frame, nucleocapsid protein, enveloped protein) Cell receptors – SARS-CoV, SARS-CoV-2: ACE2
III.22 Coronavirus transmission
Respiratory droplets
III.22 Coronavirus pathogenesis
Most coronaviruses infect and replicate the upper respiratory tract mucosa which leads to symptoms of a common cold
SARS strains replicate in respiratory tract –> viremia –> RES –> systemic infection
Extrapulmonary replication happens in GI, CNS and UT.
III.22 Coronavirus clinical
- Common cold: URT infection Mild symptoms, no fever
- SARS-CoV: LRT infection
Acute bronchitis that leads to ARDS
Flu-like illness with fever, dry cough, dyspnea, progressive hypoxia
CT shows ground glass opacities, multifocal consolidation lesions
(Pneumonia, ARDS, cytokine storm, MOF) - MERS: endemic version of SARS
III.22 Coronavirus ddx
PCR
serology
III.22 Coronavirus treatment
Supportive therapy
Antiviral treatment (i.e. HIV protease inhibitor – ritonavir) can reduce incidence of severe/critical cases
III.22 Filovirsues characteristics
ssRNA
negative sense
Helical capsid
Enveloped
III.22 Filovirsues transmission
From monkeys to human, and then human-to-human (bodily fluids)
III.22 Filovirsues clinical
- Marburg virus
- Ebola virus
Severe form of hemorrhagic fever, could lead to hypovolemic shock and multiple organ failure
III.22 Filovirsues ddx
Careful to avoid accidental infection
– level 4 isolation required
Marburg virus in tissue culture, Ebola virus in animal inoculation
Serology
RT-PCR
III.22 Filovirsues treatment
No treatment - Remdesivir
III. 23 Flavivirus - Yellow Fever, Dengue Fever characteristics
ssRNA, positive sense
Icosahedral capsid
Enveloped
III. 23 Flavivirus - Yellow Fever vector
Aedes mosquitos, hosts are humans and monkeys
III. 23 Flavivirus - Yellow Fever clinical
Yellow fever
Jaundice, backache, bloody diarrhea, nausea, vomiting, headache
III. 23 Flavivirus - Dengue Fever vector
Aedes mosquitos, hosts are humans and monkeys
III. 23 Flavivirus - Dengue Fever clinical
Dengue fever/breakbone fever:
Infects bone marrow; presents with fever, headache, vomiting, muscle/joint pain and measles-like rash that blanches when compressed
In severe dengue we can see thrombocytopenia, hemorrhagic fever, renal failure
III. 23 Flavivirus - Yellow Fever, Dengue Fever ddx
ELISA
HAI (hemagglutinin inhibition)
Latex particle agglutination
III. 23 Flavivirus - Yellow Fever, Dengue Fever treatment
supportive
III. 23 Flavivirus - Yellow Fever, Dengue Fever vaccine
yellow fever - live attenuated
III. 24 Flavivirus - West Nile, Tick Born Encephalitis, Zika Virus characteristics
ssRNA, positive sense
Icosahedral capsid
Enveloped
III. 24 Flavivirus - West Nile, Tick Born Encephalitis, Zika Virus ddx
ELISA
HAI (hemagglutinin inhibition)
Latex particle agglutination
III. 24 Flavivirus - West Nile, Tick Born Encephalitis, Zika Virus treatment
supportive
III. 24 Flavivirus - West Nile, Tick Born Encephalitis, Zika Virus prevention
inactivated vaccine - tick-borne encephalitis
III. 24 Flavivirus - Zika Virus vector
Aedes mosquitos
III. 24 Flavivirus - Zika Virus clinical
Fever, rash, myalgia, arthralgia
Congenital Zika syndrome – microcephaly, CNS damage
III. 24 Flavivirus - West Nile vector
Culex mosquitos, hosts are birds (killed by virus)
III. 24 Flavivirus - West Nile clinical
Complications; encephalitis, meningitis, flaccid paralysis, seizures, coma
III. 24 Flavivirus - tick borne encephalitis (Fruehsommer-meningo-encephalitis virus) vector
Ixodes tick, hosts are animals, tick-transovarian infection, can spread by goat milk
III. 24 Flavivirus - tick borne encephalitis (Fruehsommer-meningo-encephalitis virus) clinical
Biphasic; influenza-like symptoms, febrile illness
Aseptic meningitis/meningoencephalitis
III. 25 Calicivirus characteristics
ssRNA, positive sense
Icosahedral capsid
Naked virus
Many strains have cup-shaped depression (calyx = cup)
Divided into two genera of human pathogenic viruses; Norovirus (aka. Norwalk virus) and Sapovirus
III. 25 Calicivirus transmission
Fecal oral route
contaminated water
aerosol
III. 25 Calicivirus clinical
Nausea
vomiting
watery diarrhea – self-limiting gastroenteritis
III. 25 Calicivirus ddx
Serology
RT-PCR
radioimmunoassay
III. 25 Calicivirus treatment
rehydration
III. 25 Rotavirus characteristics
dsRNA, both positive and negative
Icosahedral capsid
Naked virus
All viruses have between 10-12 segments
All viruses have unique, double protein shell (coat) made of inner/outer capsid (resembles couch wheel)
III. 25 Rotavirus Transmission
Fecal-oral
III. 25 Rotavirus Clinical
NSP4 viral enterotoxin increases Cl- permeability which prevents absorption of water leading to - watery diarrhea - vomiting - dehydration
III. 25 Rotavirus ddx
ELISA – from stool (virion)
Blood – Ab titer
III. 25 Rotavirus treatment
supportive therpay
III. 25 Rotavirus vaccine
Live attenuated – needs to be given before 3 months or else there’s an increased risk for intussusception
III. 25 Astrovirus characteristics
ssRNA
positive sense
Icosahedral capsid
Naked virus
III. 25 Astrovirus transmission
Fecal-oral route
III. 25 Astrovirus clinical
Watery diarrhea for 2-3 days
III. 25 Astrovirus ddx
Serology
RT-PCR
III. 25 Astrovirus treatment
Supportive
III. 26 Orthomyxoviruses characteristics
ssRNA, negative sense
Helical
Enveloped
RNA synthesis in nucleus (only RNA virus)
Possesses Hemagglutinin and Neuraminidase glycoproteins
III. 26 Orthomyxoviruses transmission
Respiratory droplets, bodily fluids
III. 26 Orthomyxoviruses variation
- Antigenic drift: small, slow change of Antigen – change by point mutation.
Neutral Antibody against HA block binding to cells. Mutations in HA epitopes prevents neutral Aantibody from binding.
Influenza A, B – causes epidemic/seasonal flu
- Antigenic shift: great, fast change of Ag – co-infection of 2 different strains causes gene reassortment
Gives new subtypes due to genetic recombination of H and N segments of human and non-human species.
No cross-protective immunity against virus with new HA i.e. H1N1 - Spanish flu H2N2 - Asian flu H3N1 - Hong Kong Flu H5N1 Hong Kong avian flu
III. 26 Orthomyxoviruses pathogenesis
HA binds sialic acid on cell membrane of epithelial cells in lung/throat. Many different HA antigens (H1, H2, H3) are seen in influenza. These antigens detect cell tropism (which cell the virus can infect). Anti-HA antibodies protects the person from infection with the same stain in the future. M2 protein (a H+ channel which adjusts the pH for the virus need) gets the virus ready for viral encoding. After replication in nucleus, the virus binds host cell via the same residues as HA. NA cleaves Sialic acid from membrane to rely new virion from cell.
III. 26 Orthomyxoviruses clinical
Influenza A, B and C (also known as flu)
Upper respiratory tract infection with headache, high fever, malaise, chills, myalgia and coughing (GI symptoms in kids)
Complications include pneumonia and bronchitis
Associated with Guillan Barré syndrome: ascending paralysis, albuminocytological dissociation, elevation in CSF proteins with normal WBC count.
III. 26 Orthomyxoviruses ddx
Clinical or HA serotyping to detect virus type
III. 26 Orthomyxoviruses treatment
Amantadine (only for influenza A) and Rimantadine ~ M2 ion channel modifier
Osettamavir ~ Neuraminidase inhibition (Tamiflu)
- Aspirin is contraindicated in children after infection (Reye’s syndrome) – Fatty liver, LF, encephalitis, rash etc
III. 26 Orthomyxoviruses vaccine
Trivalent type consists of 2 A strains and 1 B strain/or tetravalent with 2A2B
- Inactivated (killed): given intramuscular
- Live attenuated: given intranasally (as spray)
III. 27 - Paramyxoviruses - Mumps, Morbillivirus characteristics
ssRNA, negative sense, non-segmented
Helical
Enveloped – HA, NA, F glycoproteins RNA synthesis in cytoplasm
III. 27 - Paramyxoviruses - Mumps clinical
Mumps virus (Rubulavirus). Enters upper respiratory tract --> spread to lymph node --> viremia.
Painful edematous enlargement of parotid and other glands ~ inflammation salivary glands, parotitis, pancreatitis, orchitis, adrenal gland etc.
Symptoms includes fever, headache and malaise. If CNS is also affected it could lead to meningoencephalitis which can eventually leads to deafness.
III. 27 - Paramyxoviruses - Mumps ddx
ELISA
HAI
III. 27 - Paramyxoviruses - Mumps prevention
live attenuated vaccine, MMR vaccine
III. 27 - Paramyxoviruses - Morbilli clinical
4 C’s; cough, coryza (runny, stuffy nose), conjunctivitis, koplik.
Symptoms include
- Koplik spots (vesicles on buccal mucosa)
- maculopapular rash (confluent, DDX from Rubella)
- acute rhinitis and conjunctivitis.
Complications are otitis media, bronchitis, giant cell pneumonia (with Warthrin-Finkeldy cells), subacute sclerosing panencephalitis (SSPE) which leads to CNS degeneration.
III. 27 - Paramyxoviruses - Morbilli ddx
ELISA
HAI
III. 27 - Paramyxoviruses - Morbilli prevention
live attenuated vaccine, MMR vaccine
III. 28 - Paramyxoviruses - RSV, Parainfluenzavirus characteristics
ssRNA, negative sense, non-segmented
Helical
Enveloped – HA, NA, F glycoproteins RNA synthesis in cytoplasm
III. 28 - Paramyxoviruses - RSV clinical
Atypical pneumonia in first year, bronchitis, bronchiole necrosis can occur
III. 28 - Paramyxoviruses - RSV characteristics
Respiratory syncitial virus (RSV)
F glycoprotein
i.e. pneumovirus
III. 28 - Paramyxoviruses - Parainfluenzavirus 1,2 clinical
Croup (laryngotracheobronchitis) in first 5 years
III. 28 - Paramyxoviruses - Parainfluenzavirus 3 clinical
Pneumonia in first year
III. 28 - Paramyxoviruses - Parainfluenzavirus 4 clinical
Upper RTI, mild catarrhal symptoms
III. 29 Picornavirus - Poliovirus characteristics
ssRNA, positive sense
Naked
Member of Enterovirus genus of the Picornaviridae family
Polio has 3 serotypes – 1, 2, and 3
III. 29 Picornavirus - Poliovirus transmission
Fecal-oral route
III. 29 Picornavirus - Poliovirus pathogenesis
Replicates in lymphoid tissue and tonsils (Peyer’s patches). Spreads (viremia) from lymphoid tissue to anterior horn of spinal cord and brain stem. Replicates in motor neurons, causing cell lysis (leading to paralysis)
III. 29 Picornavirus - Poliovirus clinical
- Asymptomatic illness – 75% of cases
- Absortive Poliomyelitis – 20% of cases (presents with URT infection and GI disturbances)
- Non-paralytic poliomyelitis – 0,1-0,5% of cases
Causes acute flaccid paralysis in which muscles become weak, floppy and paralyzed. Most commonly in lower limb (vary from 1 to 4 limbs – tetraplegia).
Depending on the site paralysis, can be classified as spinal, bulbospinal, bulbar. Bulbar polio is the most severe since it paralyzes respiratory muscles. - Post-polio syndrome – occurs 15-30 years after
Loss of muscle function (due to late harm of neurons)
III. 29 Picornavirus - Poliovirus ddx
Specimen from throat (few days) or from feces (for 30 days)
Serology
RT-PCR, virus is absent from CSF despite meningitis
III. 29 Picornavirus - Poliovirus treatment
Supportive. Iron-lung earlier (negative pressure respirator)
III. 29 Picornavirus - Poliovirus prevention
- Inactivated (killed) trivalent poliovirus vaccine (IPV) – Salk vaccine (given IM) ~ Does not form IgA
- Live attenuated bivalent poliovirus vaccine (OPV) – Sabin vaccine (given orally) ~ Forms IgA and IgG
Can infect immunocompromised, no longer used in USA/Hungary because of its potential to shed in feces.
Polio is found in three different countries today; Afghanistan, Pakistan, Nigeria
III. 30 Picornavirus - Coxasckie Virus characteristics
ssRNA, positive sense
Icosahedral capsid
Naked
III. 30 Picornavirus - Coxasckie Virus transmission
Fecal-oral route
III. 30 Picornavirus - Coxasckie Virus pathogenesis
Replicates in enterocytes and lymphocytes of intestines.
Primary viremia –> target tissue (i.e. cardiac myocyte) –> 2nd viral replication –> secondary viremia
III. 30 Picornavirus - Coxasckie Virus A clinical
- Hand, foot, mouth disease ~ usually A16 serotype
Red vesicular rash and mild fever. Appear on hands, feet and in the mouth - Herpengina
Sore throat, fever and vomiting
Vesicular ulcerated lesions around posterior part of soft palate and uvula - Acute hemorrhagic cystitis ~ usually A24 serotype
Extremely contagious, subconjunctival hemorrhages and conjunctivitis
Aseptic meningitis
III. 30 Picornavirus - Coxasckie Virus B clinical
- Pleurodynia (Bornholm disease) aka Devil’s grip
Sudden onset of fever with lower chest and pleuritic pain – unilateral - Myocarditis and pericarditis
Sudden fever, cyanosis, cardiomegaly® heart failure
Dilative cardiomyopathy
Aseptic meningitis ~ both Cox A and B
III. 30 Picornavirus - Coxasckie Virus ddx
Virus isolation – throat, stool, CSF
Inoculation in mice –> Cox A (fast, flaccid paralysis)
–> Cox B (slow, spastic paralysis)
III. 30 Picornavirus - Coxasckie Virus treatment
supportive
III. 30 Picornavirus -Rhinovirus characteristics
ssRNA, positive sense
Icosahedral capsid
Naked
III. 30 Picornavirus -Rhinovirus transmission
Respiratory droplets –> Upper respiratory tract infection
Unable to replicate in GI tract as enteroviruses
Rhinoviruses have Ag drift, as seen in influenza
III. 30 Picornavirus -Rhinovirus clinical
Upper respiratory tract infection ~ common cold
III. 30 Picornavirus - Echovirus characteristics
ssRNA, positive sense
Icosahedral capsid
Naked
III. 30 Picornavirus - Echovirus transmission
Fecal-oral route –> can infect any tissue (broad tropism)
III. 30 Picornavirus - Echovirus clinical
Gastroenteritis Boston-exanthema (fever, sore throat, exanthemas) maculopapular rash aseptic meningitis (~ nr.1 cause) necrotizing hepatitis in neonates
III. 30 Picornavirus - Enterovirus characteristics
ssRNA, positive sense
Icosahedral capsid
Naked
III. 30 Picornavirus - Enterovirus D68 clinical
EV-D68, infants, children and teens. Mild to severe respiratory illness, however, the full spectrum of EV-D68 is not well defined. Most start with common cold symptoms of runny nose and cough. Some, but not all, may also have fever. For more severe cases, difficulty breathing, wheezing or problems catching your breath may occur.
III. 30 Picornavirus - Enterovirus A71 clinical
One of the major causative agents for hand, foot and mouth disease, and is sometimes associated with severe central nervous system diseases. Increases in the level of mRNAs encoding chemokines, proteins involved in protein degradation, complement proteins, and pro-apoptosis proteins have been implicated.